Meta AnalysisID 2842

菊粉型果聚糖和餐后胃肠激素反应:随机对照试验的系统评价

CRD42021273438

Does inulin-type fructans supplementation affect postprandial gastrointestinal hormone responses in humans?

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
2842
Evidence Id
11400
Core Evidence Id
11400
Source Meta Analysis Id
2784
Herb2 Meta Analysis Id
HBMA002784
Crd Id
CRD42021273438
Title
Inulin-type fructans and postprandial gastrointestinal hormone responses: a systematic review of randomised controlled trials
Review Question
Does inulin-type fructans supplementation affect postprandial gastrointestinal hormone responses in humans?
Study Type Included
Human studies - Randomised controlled trials (RCTs)
Condition Being Studied
Gastrointestinal hormones are secreted as a sign of nutrients arrival and energy intake; they communicate directly or indirectly with the brain to alter food intake and reward via their widely spread receptors. Inulin, a water-soluble non-digestible carbohydrate, is fermented by the gut microflora eliciting beneficial effects on glycaemic control (Wang et al. 2019) and blood lipids profile (Liu et al. 2017) and has also shown benefits on weight management (Liber & Szajewska 2013). In this systematic review we are interested to investigate whether inulin-type fructans supplementation has any effects on postprandial gastrointestinal hormone responses.
Participant
Adults older than 18 years old, any health status.
Animal
Human Disease Modelled
Intervention
All randomised controlled trials examining the effects of inulin-type fructans supplementation in any form (as a supplement per se or incorporated into food products), irrespective of their degree of polymerisation chain length (e.g. oligofructose, inulin, fructans, fructooligosaccharides from chicory, artichoke, agave etc) and not in combination with any other bioactive components.
Comparator Control
Non-inulin control, placebo.
Main Outcome
The main outcome is postprandial gastrointestinal hormone responses associated with inulin-type fructans supplementation. The RCTs should include at least one gut hormone (glucagon-like peptide 1 (GLP-1), peptide YY (PYY), gastroinhibitory peptide (GIP), ghrelin, cholecystokinin (CCK), or other) measured postprandially in order to be eligible. Studies assessing only fasting concentrations of gut hormones will not be included.
Outcome Measure
Additional Outcome
Secondary outcomes include subjective appetite ratings (e.g. VAS) and energy intake (described only for already included studies for the primary outcome).
Study Method
Narrative synthesis, Systematic review
Keyword
Fructans; Gastrointestinal Hormones; Humans; Inulin; Postprandial Period
Contact
Nikoleta Stamataki [email protected]
Organisational Affiliation
University of Manchester, Harokopio University of Athens
Funding Source
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
England, Greece
Review Stage
Review Ongoing
First Submission Date
2021-08-17
Registration Date
2021-09-15
Anticipated Start Date
2021-08-23
Anticipated Completion Date
2022-01-31
Title Cn
菊粉型果聚糖和餐后胃肠激素反应:随机对照试验的系统评价
Title En
Inulin-type fructans and postprandial gastrointestinal hormone responses: a systematic review of randomised controlled trials
Bilingual Status
complete